Sinovac Biotech Company Profile (NASDAQ:SVA)

About Sinovac Biotech (NASDAQ:SVA)

Sinovac Biotech logoSinovac Biotech Ltd. (Sinovac) is a holding company. The Company is a biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases, including hepatitis A, hepatitis B, seasonal influenza, Haemagglutinase5 Neuraminidase1 (H5N1) and Influenza A (H1N1) pandemic influenza and mumps. The Company's pipeline consists of vaccine candidates in the clinical and pre-clinical development Phases in China. The Company is engaged in the sales, marketing, manufacturing and development of vaccines for infectious disease. The Company develops various products, including Healive, Bilive, Anflu, Panflu Whole Viron Pandemic Influenza Vaccine, Split Viron Pandemic Influenza Vaccine, Panflu.1, RabEnd, Mumps Vaccine, Enterovirus 71 (EV71) Vaccine, Pneumococcal Polysaccharide Vaccine, Pneumococcal Conjugate Vaccine, Rubella Vaccine, Varicella Vaccine and Sabin Inactivated Polio Vaccine.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biopharmaceuticals
  • Sub-Industry: N/A
  • Symbol: NASDAQ:SVA
  • CUSIP: N/A
  • Web: www.sinovac.com
Capitalization:
  • Market Cap: $391.72 million
  • Outstanding Shares: 56,968,000
Average Prices:
  • 50 Day Moving Avg: $6.08
  • 200 Day Moving Avg: $5.74
  • 52 Week Range: $4.60 - $6.94
P/E:
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $64.02 million
  • Price / Sales: 6.10
  • Book Value: $2.02 per share
  • Price / Book: 3.40
Profitability:
  • EBIDTA: ($837,000.00)
Misc:
  • Average Volume: 147,927 shs.
  • Beta: 0.05
  • Short Ratio: 2.72
 

Frequently Asked Questions for Sinovac Biotech (NASDAQ:SVA)

What is Sinovac Biotech's stock symbol?

Sinovac Biotech trades on the NASDAQ under the ticker symbol "SVA."

How were Sinovac Biotech's earnings last quarter?

Sinovac Biotech, Ltd. (NASDAQ:SVA) announced its earnings results on Tuesday, August, 23rd. The company reported ($0.15) earnings per share for the quarter. The company had revenue of $1.38 billion for the quarter, compared to analysts' expectations of $18.49 billion. During the same quarter in the prior year, the firm posted $0.02 earnings per share. View Sinovac Biotech's Earnings History.

Who are some of Sinovac Biotech's key competitors?

Who are Sinovac Biotech's key executives?

Sinovac Biotech's management team includes the folowing people:

  • Weidong Yin, Chairman of the Board, President, Chief Executive Officer, Secretary
  • Nan Wang, Chief Financial Officer
  • Ming Xia, Vice President - Sales and Marketing of Sinovac Beijing
  • Simon J. Anderson, Independent Director
  • Jue Lee, Independent Director
  • Yuk Lam Lo, Independent Director
  • Meng Mei, Independent Director

Who owns Sinovac Biotech stock?

Sinovac Biotech's stock is owned by a number of of institutional and retail investors. Top institutional investors include SAIF Advisors Ltd (18.92%) and Eqis Capital Management Inc. (0.28%). View Institutional Ownership Trends for Sinovac Biotech.

Who bought Sinovac Biotech stock? Who is buying Sinovac Biotech stock?

Sinovac Biotech's stock was bought by a variety of institutional investors in the last quarter, including Eqis Capital Management Inc.. View Insider Buying and Selling for Sinovac Biotech.

How do I buy Sinovac Biotech stock?

Shares of Sinovac Biotech can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Sinovac Biotech's stock price today?

One share of Sinovac Biotech stock can currently be purchased for approximately $6.86.


MarketBeat Community Rating for Sinovac Biotech (NASDAQ SVA)
Community Ranking:  2.4 out of 5 ( )
Outperform Votes:  39 (Vote Outperform)
Underperform Votes:  42 (Vote Underperform)
Total Votes:  81
MarketBeat's community ratings are surveys of what our community members think about Sinovac Biotech and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Sinovac Biotech (NASDAQ:SVA) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Sinovac Biotech (NASDAQ:SVA)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Sinovac Biotech (NASDAQ:SVA)
Earnings by Quarter for Sinovac Biotech (NASDAQ:SVA)
Earnings History by Quarter for Sinovac Biotech (NASDAQ SVA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/28/2016Q316$0.05$0.06$16.76 million$28.74 millionViewN/AView Earnings Details
8/23/2016Q2($0.15)$18.49 billion$1.38 billionViewListenView Earnings Details
5/26/2016Q116($0.01)$10.95 millionViewN/AView Earnings Details
4/5/2016Q415$0.01$22.95 millionViewN/AView Earnings Details
11/11/2015Q315($0.02)($0.03)$27.10 million$16.80 millionViewListenView Earnings Details
8/12/2015Q215($0.01)$0.04$15.70 million$18.50 millionViewListenView Earnings Details
5/15/2015Q115$0.02($0.04)$12.70 million$9.27 millionViewN/AView Earnings Details
4/20/2015Q414$0.01$0.02$14.10 million$22.90 millionViewN/AView Earnings Details
8/14/2014Q214$0.01($0.04)$17.20 million$12.10 millionViewN/AView Earnings Details
3/19/2014Q4 13($0.01)$0.10$18.75 million$22.90 millionViewN/AView Earnings Details
11/12/2013Q3$0.04ViewListenView Earnings Details
11/15/2012Q312($0.03)($0.06)$12.35 million$14.30 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Sinovac Biotech (NASDAQ:SVA)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Sinovac Biotech (NASDAQ:SVA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Sinovac Biotech (NASDAQ:SVA)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Sinovac Biotech (NASDAQ:SVA)
Latest Headlines for Sinovac Biotech (NASDAQ:SVA)
Source:
DateHeadline
finance.yahoo.com logoSVA INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Sinovac Biotech Ltd. and a Lead Plaintiff Deadline of September 1, 2017
finance.yahoo.com - July 20 at 8:13 AM
finance.yahoo.com logoINVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - July 20 at 8:13 AM
finance.yahoo.com logoSeptember 1st Deadline Alert: GPM Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Sinovac Biotech Ltd.
finance.yahoo.com - July 19 at 7:51 AM
finance.yahoo.com logoSVA SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Sinovac Biotech Ltd. and a Lead Plaintiff Deadline of September 1, 2017
finance.yahoo.com - July 19 at 7:51 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - July 19 at 7:51 AM
finance.yahoo.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Sinovac Biotech Ltd. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 1, 2017
finance.yahoo.com - July 18 at 8:40 AM
finance.yahoo.com logoSHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Sinovac Biotech Ltd. (SVA) & Lead Plaintiff Deadline: September 1, 2017
finance.yahoo.com - July 15 at 9:09 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Sinovac Biotech Ltd. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 1, 2017 – SVA
finance.yahoo.com - July 15 at 9:09 AM
finance.yahoo.com logoEQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Sinovac Biotech Ltd. - SVA
finance.yahoo.com - July 15 at 9:09 AM
finance.yahoo.com logoThe Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Sinovac Biotech Ltd. Investors and Encourages Investors to Contact the Firm
finance.yahoo.com - July 15 at 9:09 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - July 15 at 9:09 AM
feeds.benzinga.com logoEQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Sinovac Biotech Ltd. - SVA
feeds.benzinga.com - July 14 at 4:55 PM
businesswire.com logoThe Klein Law Firm Reminds Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Sinovac Biotech Ltd (SVA)
www.businesswire.com - July 14 at 8:50 AM
finance.yahoo.com logoINVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - July 14 at 8:50 AM
finance.yahoo.com logoINVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Sinovac Biotech Ltd. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
finance.yahoo.com - July 14 at 8:50 AM
finance.yahoo.com logoThe Klein Law Firm Notifies Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Sinovac Biotech Ltd
finance.yahoo.com - July 13 at 10:02 AM
finance.yahoo.com logoIMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - July 13 at 10:02 AM
businesswire.com logoSVA INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Sinovac ...
www.businesswire.com - July 11 at 8:58 PM
finance.yahoo.com logoIMPORTANT EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - July 11 at 8:58 PM
finance.yahoo.com logoSVA INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Sinovac Biotech Ltd
finance.yahoo.com - July 11 at 8:10 AM
businesswire.com logoSVA INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Sinovac ...
www.businesswire.com - July 8 at 2:30 PM
finance.yahoo.com logoSVA INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Sinovac Biotech Ltd
finance.yahoo.com - July 8 at 2:30 PM
finance.yahoo.com logoIMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - July 8 at 2:30 PM
finance.yahoo.com logoSVA LOSS NOTICE: Rosen Law Firm Reminds Sinovac Biotech Ltd. Investors of Important Deadline in First Filed Class Action - SVA
finance.yahoo.com - July 8 at 2:30 PM
finance.yahoo.com logoIMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - July 8 at 2:30 PM
finance.yahoo.com logoIMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - July 6 at 9:26 PM
finance.yahoo.com logoGlancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Sinovac Biotech Ltd. Investors and Encourages Investors to Contact the Firm
finance.yahoo.com - July 6 at 9:26 PM
finance.yahoo.com logoIMPORTANT INVESTOR ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - July 6 at 9:26 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Goldberg Law PC Announces the Filing of a Securities Class Action Lawsuit against Sinovac Biotech Ltd.
finance.yahoo.com - July 6 at 9:25 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Sinovac Biotech Ltd. (Nasdaq: SVA) To Contact Brower Piven Before The Lead Plaintiff Deadline
finance.yahoo.com - July 6 at 9:25 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Sinovac Biotech Ltd
finance.yahoo.com - July 6 at 4:24 PM
businesswire.com logoSINOVAC LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Sinovac Biotech, Ltd. To Contact The Firm
www.businesswire.com - July 6 at 11:21 AM
finance.yahoo.com logoIMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - July 6 at 11:21 AM
finance.yahoo.com logoEQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Sinovac Biotech Ltd. - SVA
finance.yahoo.com - July 4 at 7:43 AM
finance.yahoo.com logoIMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - July 4 at 7:43 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Sinovac Biotech Ltd. (SVA) & Lead Plaintiff Deadline: September 1, 2017
finance.yahoo.com - July 4 at 7:43 AM
finance.yahoo.com logoINVESTOR ALERT: Goldberg Law PC Announces the Filing of a Securities Class Action Lawsuit against Sinovac Biotech Ltd.
finance.yahoo.com - July 4 at 7:43 AM
americanbankingnews.com logoSinovac Biotech, Ltd. (NASDAQ:SVA) Rating Increased to Hold at ValuEngine
www.americanbankingnews.com - July 1 at 9:28 AM
finance.yahoo.com logoUPDATE: To Acquire Sinovac Biotech (Nasnaq: SVA) Sinobioway Consortium Raises Its Purchase Price To $8 Per Share
finance.yahoo.com - July 1 at 7:56 AM
finance.yahoo.com logoTo Fight Against The Behavior Between Sinovac's Special Committee And Weidong Yin's Consortium And Their Low Price, Sinobioway Consortium Raises Its Purchase Price To $8 Per Share
finance.yahoo.com - June 29 at 7:09 AM
streetinsider.com logoSinovac Biotech (SVA) Announces $401.8M Acquisition by Parent Company to go Private
www.streetinsider.com - June 27 at 8:09 PM
rttnews.com logoSinovac Biotech To Be Acquired By Parent For Around $401.8 Mln
www.rttnews.com - June 27 at 8:09 PM
finance.yahoo.com logoSINOVAC INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sinovac Biotech Ltd.
finance.yahoo.com - June 27 at 8:09 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Into Whether the Sale of Sinovac Biotech Ltd. to Sinovac (Cayman) Limited and Sinovac Amalgamation Sub Limited for $7.00 Per Share is Fair to Shareholders
finance.yahoo.com - June 27 at 8:50 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Brower Piven Commences an Investigation into the Proposed Sale of Sinovac Biotech Ltd. and Encourages Investors to Contact the Firm for Additional Information
finance.yahoo.com - June 27 at 8:50 AM
finance.yahoo.com logoSinovac Biotech Ltd. – Value Analysis (NASDAQ:SVA) : June 16, 2017
finance.yahoo.com - June 17 at 6:28 AM
finance.yahoo.com logoSinovac Biotech Ltd. breached its 50 day moving average in a Bullish Manner : SVA-US : June 15, 2017
finance.yahoo.com - June 15 at 4:29 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Sinovac Biotech Ltd. Investors
finance.yahoo.com - May 27 at 6:06 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Sinovac Biotech Ltd.
finance.yahoo.com - May 27 at 6:06 AM
finance.yahoo.com logoIMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of Sinovac Biotech Ltd. and Advises Investors with Losses to Contact the Firm
finance.yahoo.com - May 19 at 12:55 PM

Social

Chart

Sinovac Biotech (SVA) Chart for Thursday, July, 20, 2017

This page was last updated on 7/20/2017 by MarketBeat.com Staff